Both in Pharmaceuticals
TG Therapeutics vs Cytokinetics
Over the past year TGTX returned +82.3% and CYTK returned +6.7%; their daily moves had a correlation of 0.25.
TGTX +82.3% CYTK +6.7%Growth of $1, one year, split-adjusted
| Metric | TGTX | CYTK |
|---|---|---|
| Price | $61.63 | $63.60 |
| Market cap | $9.43B | $8.84B |
| Today | +1.45% | +2.07% |
| 1 month | +18.1% | +3.7% |
| 6 months | +46.8% | −15.0% |
| Year to date | +106.7% | +0.1% |
| 1 year | +82.9% | +5.9% |
| Revenue growth (YoY) | +70.3% | −57.1% |
| Gross margin | 82.9% | 90.5% |
| Net margin | 3.2% | −694.4% |
| P/E (TTM) | 21.4× | — |
| Price / sales | 11.8× | 130.7× |
| Net cash | -$193.1M | $18.6M |
| Dividend yield | — | — |
| Volatility (60d) | 36.8% | 32.0% |
| Short % of float | 20.1% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).